The Pharmacogenomics Journal - Issue - nature.com science feeds

The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications.

Latest articles

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization

The Pharmacogenomics Journal, Published online: 23 July 2020; doi:10.1038/s41397-020-0178-xCorrection: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China

The Pharmacogenomics Journal, Published online: 23 July 2020; doi:10.1038/s41397-020-0177-yGenetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China

Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?

The Pharmacogenomics Journal, Published online: 18 July 2020; doi:10.1038/s41397-020-0175-0Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?

Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?

Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

The Pharmacogenomics Journal, Published online: 18 July 2020; doi:10.1038/s41397-020-0176-zGene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

<i>ERCC2</i> gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

<i>ERCC2</i> gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

The Pharmacogenomics Journal, Published online: 16 June 2020; doi:10.1038/s41397-020-0174-1ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Discover, share and read the best on the web

Subscribe to RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters! Get unfiltered news feeds or filter them to your liking.

Get Inoreader
Inoreader - Subscribe to RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters!